Article info
PDFCardiovascular medicine
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease
- Correspondence to:
Dr Simon Robinson
Centre for Cardiovascular Sciences, University of Edinburgh, Royal Infirmary of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB, UK; simon.robinson{at}ed.ac.uk
Citation
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease
Publication history
- First published April 29, 2005.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Heart